Charles Chuah
SingHealth(SG)Guy's and St Thomas' NHS Foundation Trust(GB)Singapore General Hospital(SG)SingHealth Duke-NUS Academic Medical Centre(SG)Mahsa University(MY)Duke-NUS Medical School(SG)National Cancer Centre Singapore(SG)Signature Research (United States)(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia(2010)1,574 cited
- → A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias(2013)1,111 cited
- → Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial(2016)926 cited
- → Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial(2018)576 cited
- → A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer(2012)552 cited
- → Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial(2017)483 cited